Sitemap > Breaking Research > Immunology & Inflammatory Diseases
Displaying 1501 - 1550 of 5698 results
- Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines.
- Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model.
- Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody.
- Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.
- Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.
- Effects of Delta12-prostaglandin J2 on bone regeneration and growth factor expression in rats.
- Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.
- The melanocortin peptide HP228 displays protective effects in acute models of inflammation and organ damage.
- Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss.
- A microplate assay for the screening of ADAMTS-4 inhibitors.
- In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI.
- Particularities of the vasculature can promote the organ specificity of autoimmune attack.
- Autoimmunity and tumor immunity induced by immune responses to mutations in self.
- Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity.
- Bradykinin B2 receptor antagonism attenuates inflammation, mast cell infiltration and fibrosis in remote myocardium after infarction in rats.
- Synthesis and evaluation of NO-release from symmetrically substituted furoxans.
- Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial.
- Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations.
- Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
- Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis.
- The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden.
- Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
- Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.
- NOS2 regulates cytokine production and VLA-4 expression in experimental autoimmune encephalomyelitis.
- Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis.
- Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus.
- Matrix metalloproteinase inhibitor (ONO-4817) attenuates ischemia-reperfusion injury in rat lung.
- Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A.
- Beta-substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin K.
- New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity.
- Inhibition of Rho-kinase normalizes nonspecific hyperresponsiveness in passively sensitized airway smooth muscle preparations.
- A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes.
- Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.
- N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
- CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn.
- The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials.
- CD28-dependent differentiation into the effector/memory phenotype is essential for induction of arthritis in interleukin-1 receptor antagonist-deficient mice.
- High-throughput multi-antigen microfluidic fluorescence immunoassays.
- Purified human bone marrow multipotent mesenchymal stem cells regenerate infarcted myocardium in experimental rats.
- Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis.
- Role of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in the regulation of blood pressure by leptin in lean and obese rats.
- Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
- Pyridone derivatives as potent and selective VLA-4 integrin antagonists.
- Potent blockers of the monocarboxylate transporter MCT1: novel immunomodulatory compounds.
- Attenuation of skeletal muscle reperfusion injury with intravenous 12 amino acid peptides that bind to pathogenic IgM.
- Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus.
- CCL5 modulates pneumococcal immunity and carriage.
- Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37.
- OX40 ligation of CD4+ T cells enhances virus-specific CD8+ T cell memory responses independently of IL-2 and CD4+ T regulatory cell inhibition.
- Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | 113 | 114 Next >